Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/26/25 20:00 | 6/24/25 | KALA | Health | Drug | Pharmaceutical Preparations | Kharabi Darius | MA | O | CHIEF BU | 2 | S | -21 | 3.97 | 0 | -5 | 67 | D | |||||||||||||||
6/26/25 20:00 | 6/24/25 | KALA | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | 2 | S | -25 | 3.89 | 0 | -6 | 66 | D | |||||||||||||||
6/26/25 20:00 | 6/24/25 | KALA | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | SEE REMA | 2 | S | -29 | 3.89 | 0 | -7 | 88 | D | |||||||||||||||
6/26/25 20:00 | 6/24/25 | KALA | Health | Drug | Pharmaceutical Preparations | Brazzell Romulus K | MA | O | SEE REMA | 2 | S | -35 | 3.90 | 0 | -9 | 88 | D | |||||||||||||||
6/26/25 20:00 | 6/24/25 | KALA | Health | Drug | Pharmaceutical Preparations | Iwicki Mark T | MA | D | 3 | S | -134 | 3.84 | 0 | -35 | 269 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |